GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Nutriband Inc.
Nutriband develops transdermal drug delivery patches. Its stock price represents a venture capital bet on the success of its technology. The chart reflects high volatility associated with news about clinical trials and partnerships.
Share prices of companies in the market segment - Narco farm
Nutriband develops transdermal drug delivery patches, including an opioid abuse prevention system and cannabidiol (CBD) patches. We've classified it in the "Narco Farm" segment due to its focus on controlled substances. The chart below reflects the dynamics in this complex, regulated biopharmaceutical sector.
Broad Market Index - GURU.Markets
Nutriband is a company developing transdermal drug delivery patches. As a participant in this sector, it is included in our GURU.Markets index. The chart below reflects the overall stock market performance. Compare it with the company's stock price to assess the industry's prospects.
Change in the price of a company, segment, and market as a whole per day
NTRB - Daily change in the company's share price Nutriband Inc.
Nutriband Inc.'s daily price change reflects the high volatility inherent in companies developing transdermal patches. This indicator is a measure of sensitivity to news about clinical trials and partnerships, serving as a risk assessment tool.
Daily change in the price of a set of shares in a market segment - Narco farm
Nutriband Inc.'s daily price change reflects the high volatility inherent in companies developing transdermal patches. This indicator is a measure of sensitivity to news about clinical trials and partnerships, serving as a risk assessment tool.
Daily change in the price of a broad market stock, index - GURU.Markets
Nutriband develops transdermal patches for drug delivery, including for the cannabis market. The company operates at the intersection of pharmaceuticals and emerging consumer trends. Its stock is volatile and dependent on research advances, contributing to market dynamics.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Nutriband Inc.
For Nutriband Inc., year-over-year performance is a story about the development of its transdermal patches. Its 12-month market cap depends on progress in developing its key product—a patch that combines an opioid analgesic with an antagonist to prevent abuse, a crucial step in the fight against the opioid crisis.
Annual dynamics of market capitalization of the market segment - Narco farm
Nutriband Inc. is a pharmaceutical company developing transdermal drug delivery patches. Its stock performance is entirely dependent on clinical trial results and partnerships. The chart reflects the high risks and potential for breakthroughs inherent to this sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Nutriband is a very small and highly speculative pharmaceutical company. Its stock price has nothing to do with fundamentals or the economy, but is driven by news of trials and investor confidence in the potential of its developments, making it a high-risk bet.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Nutriband Inc.
Nutriband develops transdermal drug delivery patches. Its monthly performance reflects progress in the development and approval of its products. News of partnerships with pharmaceutical companies or successful clinical trials are key drivers.
Monthly dynamics of market capitalization of the market segment - Narco farm
Nutriband Inc. is a biopharmaceutical company developing transdermal drug delivery patches. The dynamics of its sector, shown in the chart, reflect the risks of R&D. Against this backdrop, it's possible to assess how its patented technology, aimed at preventing opioid patch abuse, could solve a significant healthcare problem.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Nutriband develops transdermal drug delivery patches. It's a medical startup whose stock moves on news of development progress and partnerships. The stock price will exhibit high volatility and weak correlation with the market, as investors evaluate the technology's potential rather than current revenue.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Nutriband Inc.
Nutriband, a company developing transdermal drug delivery patches, is experiencing high volatility. Weekly stock performance is driven by news about clinical trials and partnerships, reflecting the risks and potential of innovative drug delivery methods.
Weekly dynamics of market capitalization of the market segment - Narco farm
Nutriband develops transdermal drug delivery patches, including unique solutions for opioid abuse prevention. This chart compares its performance with the pharmaceutical sector and helps understand how the market views its innovative technology against broader industry trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Nutriband develops transdermal patches. As a development-stage biotech company, its shares are highly volatile. The chart shows that their movements are driven by technology and partnership news, rather than general market trends.
Market capitalization of the company, segment and market as a whole
NTRB - Market capitalization of the company Nutriband Inc.
Nutriband's stock price is a financial bet on transdermal patches. The market cap of this company, which develops drug delivery patches, reflects its belief in this convenient method of administration. Its performance also demonstrates its promise for its technology, which aims to make opioid patches safer by preventing their misuse.
NTRB - Share of the company's market capitalization Nutriband Inc. within the market segment - Narco farm
Nutriband's market share in the pharmaceutical sector reflects its focus on developing transdermal drug delivery patches. Its market share is driven by the potential of its technology, particularly in creating abuse-resistant patches for opioid analgesics.
Market capitalization of the market segment - Narco farm
Nutriband develops transdermal drug delivery patches. The chart below shows the overall market capitalization of the entire pharmaceutical industry. Its dynamics provide the backdrop against which Nutriband offers a more convenient and effective method of drug delivery.
Market capitalization of all companies included in a broad market index - GURU.Markets
Nutriband develops transdermal patches for drug delivery through the skin. Its market capitalization is a bet on this convenient technology. The chart below shows the economic weight of companies working on new methods of therapeutic delivery.
Book value capitalization of the company, segment and market as a whole
NTRB - Book value capitalization of the company Nutriband Inc.
For Nutriband, which develops transdermal patches, book value is its R&D equipment and capital. The chart below shows the financial resources for its innovative developments. This level is an indicator of the company's ability to finance clinical trials and product launches.
NTRB - Share of the company's book capitalization Nutriband Inc. within the market segment - Narco farm
Nutriband develops transdermal drug delivery patches. The company's value lies in its technology, but production requires certified facilities. The asset share chart shows how the company is building its physical base for producing innovative products.
Market segment balance sheet capitalization - Narco farm
Nutriband develops transdermal patches. Its assets are not giant factories, but rather advanced R&D labs and pilot production lines. This is capital-intensive R&D. The chart illustrates how dependent the entire medical technology sector is on investment in innovation, backed by physical assets.
Book value of all companies included in the broad market index - GURU.Markets
Nutriband's balance sheet is intellectual property for the development of transdermal drug delivery patches. The company's assets represent capital invested in technology that can offer a convenient and effective alternative to pills and injections for various therapeutic areas.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Nutriband Inc.
Nutriband develops transdermal drug delivery patches. The company has no significant tangible assets. Its market capitalization is a bet on its patented technology and its ability to partner with pharmaceutical companies. The chart reflects the risks and potential of this innovative drug delivery method.
Market to book capitalization ratio in a market segment - Narco farm
Nutriband develops transdermal drug delivery patches. It's a pharmaceutical technology company. Its value is based almost entirely on the potential of its developments. The chart shows how much investor expectations for its technology exceed the value of its current tangible assets.
Market to book capitalization ratio for the market as a whole
Nutriband develops transdermal drug delivery patches. The chart shows the market valuation of a company with an innovative drug delivery technology. The company's market capitalization reflects a bet that its technology will be adopted by pharmaceutical companies to create more convenient versions of existing and new drugs.
Debts of the company, segment and market as a whole
NTRB - Company debts Nutriband Inc.
Nutriband is developing transdermal drug delivery patches. While in the development and approval stages, the company is seeking funding for R&D and clinical trials. This chart shows how Nutriband is raising capital to bring its innovative products to the pharmaceutical market.
Market segment debts - Narco farm
Nutriband develops transdermal drug delivery patches. Their technology is aimed at improving the delivery of active ingredients. This chart shows general financial metrics for the pharmaceutical sector, which can be used to assess how the company is funding its research and development to commercialize its innovative drug delivery platform.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Nutriband Inc.
Nutriband develops transdermal drug delivery patches. The company operates at the intersection of pharmaceuticals and medical technology. This chart shows the role debt plays in funding its research, development, and product launches. For investors, this is a way to assess the company's financial strength as it moves toward commercialization.
Market segment debt to market segment book capitalization - Narco farm
The development of transdermal drug delivery patches like Nutriband is an innovative technology in the pharmaceutical industry. This chart shows how the sector as a whole funds its R&D. It allows us to appreciate how Nutriband's financial model, operating at the intersection of pharmaceuticals and medical devices, differs from that of traditional pill manufacturers.
Debt to book value of all companies in the market
Nutriband develops transdermal drug delivery patches. Pharmaceutical development, even in such niche areas, requires capital for research and clinical trials. The chart provides context for evaluating their leverage strategy compared to pharmaceutical giants and the overall market.
P/E of the company, segment and market as a whole
P/E - Nutriband Inc.
This metric for Nutriband Inc., a company developing transdermal drug delivery patches, reflects faith in its technology. For a company in the development stage, its value is determined not by current profits, but by the potential of its products, including a patch for opioid abuse prevention.
P/E of the market segment - Narco farm
This indicator represents the average valuation for the biotech sector in which Nutriband operates. It reflects the overall level of hope and expectation in the development of new drug delivery systems. The chart serves as a barometer of investor confidence in the future of transdermal technologies.
P/E of the market as a whole
Nutriband develops transdermal drug delivery patches. The company is working on pain management products, as well as a patch that prevents opioid abuse. This chart shows sentiment in the pharmaceutical sector. It helps understand how the market views the potential of transdermal delivery technology and its application in such a socially significant area as combating the opioid crisis.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Nutriband Inc.
Nutriband develops transdermal drug delivery patches. Its key development is a patch with aversion technology to prevent opioid abuse. The company's future depends on regulatory approval and commercialization of this technology. This chart shows market expectations regarding its potential to combat the opioid crisis and other applications of its platform.
%20P%2FE%20Nutriband%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Nutriband-Inc.&v=1772513916162 "Chart of the company's future (projected) P/E Nutriband Inc.")
Future (projected) P/E of the market segment - Narco farm
Nutriband develops transdermal drug delivery patches. The company works both on its own products and in partnership with other pharmaceutical companies. This chart reflects expectations for the biotech sector, providing context for assessing the market's perception of this drug delivery technology and its commercial potential.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772513916172 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Nutriband develops transdermal drug delivery patches. Their innovations are aimed at creating patches that prevent opioid abuse. This graph of overall expectations shows investor sentiment toward pharmaceutical innovation. Market optimism facilitates capital raising for the development and clinical trials of products that address important healthcare challenges.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513916192 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Nutriband Inc.
Nutriband develops transdermal drug delivery systems (patches). This chart shows the company's financial performance during the development and commercialization stages. Revenue will depend on the approval and commercialization of its products, including patches for the delivery of both prescription and over-the-counter medications.
Profit of companies in the market segment - Narco farm
Snail, Inc. is a video game developer and publisher. Its profitability depends on creating hit games and monetizing them. This chart reflects the nature of the gaming industry: it's a hit-driven business, where one successful project can generate huge profits and cover the costs of many unsuccessful ones, making financial results highly volatile.
Overall market profit
Nutriband develops transdermal drug delivery patches. The company focuses on improving existing therapies through a new delivery method. Its success depends on clinical development results and the ability to demonstrate the advantages of its technology over traditional pills or injections.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Nutriband Inc.
Nutriband develops transdermal drug delivery patches. The company is in the development stage, and its primary focus is on creating a patch for opioid abuse prevention. Revenue projections are long-term and depend on the success of clinical trials and regulatory approval. This chart reflects analysts' speculative expectations.
%20profit%20of%20the%20company%20Nutriband%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Nutriband-Inc.&v=1772513916276 "Graph of future (projected) profit of the company Nutriband Inc.")
Future (predicted) profit of companies in the market segment - Narco farm
Nutriband develops transdermal drug delivery patches. The company is working on patches with technology that prevents opioid abuse. This represents a significant innovation in drug safety. This graph shows profitability forecasts for the pharmaceutical sector. It reflects the need for new delivery technologies that address pressing healthcare challenges.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772513916277 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Nutriband Inc. develops transdermal patches for drug delivery, including for the treatment of opioid abuse. Demand for its products is driven by medical needs. However, the overall economic outlook, reflected in this chart, impacts the availability of funding for clinical trials and commercialization of new products.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513916327 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Nutriband Inc.
Nutriband is a company specializing in the development of transdermal drug delivery patches. Its key development is aimed at creating an opioid patch with abuse-resistant properties. The chart reflects investor sentiment regarding its technology, which could help combat the opioid crisis.
P/S market segment - Narco farm
Nutriband Inc. is a biopharmaceutical company developing transdermal drug delivery patches, including those for opioid abuse and contraception. This chart shows the average valuation in the sector, allowing one to assess the market's perception of the revenue potential of Nutriband's innovative drug delivery technologies.
P/S of the market as a whole
Nutriband develops transdermal drug delivery patches. The company is working on creating patches that could replace injections for various therapeutic purposes. This chart, showing average valuations, clearly highlights the gap between the valuations of traditional businesses and companies developing innovative drug delivery systems.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Nutriband Inc.
Nutriband develops transdermal drug delivery patches. This chart reflects investor expectations for the future success of its technologies. The valuation is based on potential revenue from its developments, including patches for delivering painkillers and other active ingredients through the skin, which offer an alternative to pills.
%20P%2FS%20Nutriband%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Nutriband-Inc.&v=1772513916393 "The graph of the company's future (projected) P/S Nutriband Inc.")
Future (projected) P/S of the market segment - Narco farm
Nutriband Inc. develops transdermal drug delivery patches. One of its key developments is a patch with opioid abuse prevention technology. The chart shows how investors estimate Nutriband's future sales, reflecting the potential of its innovative technologies in the pharmaceutical industry.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772513916394 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
This chart reflects innovations in drug delivery. Nutriband is developing transdermal patches for delivering medications through the skin. Their technologies could make drug administration more convenient and safe. Interest in such developments demonstrates the market's belief in the potential of new delivery methods to improve therapeutics and create new products.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513916400 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Nutriband Inc.
Nutriband is developing transdermal drug delivery patches. The company is in the development stage, and its revenue may currently be negligible, coming from sales of existing products or partnerships. This chart reflects its progress toward commercialization of its core technology, which is expected to become its primary source of revenue in the future.
Sales of companies in the market segment - Narco farm
Nutriband Inc. develops transdermal patches for drug delivery. Its flagship product is an opioid abuse patch that becomes inactive when heated. This graph shows total revenue in the cannabis sector, illustrating the search for innovative solutions to combat the opioid crisis and other medical challenges.
Overall market sales
Nutriband is a company developing transdermal drug delivery patches. Its key development is aimed at creating a fentanyl patch with abuse-deterrent properties. Success depends on regulatory approval. This development is influenced by the overall economic climate, which impacts the availability of funding for pharmaceutical companies in the development stage.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Nutriband Inc.
Nutriband develops transdermal drug delivery patches. The company is working on creating patches with opioid abuse prevention technology. The future depends on the success of these developments. The chart shows analysts' speculative forecasts, which are betting on the commercialization of its innovative drug delivery technologies.
%20sales%20of%20the%20company%20Nutriband%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Nutriband-Inc.&v=1772513916489 "Schedule of future (projected) sales of the company Nutriband Inc.")
Future (projected) sales of companies in the market segment - Narco farm
Nutriband develops transdermal drug delivery patches. The company focuses on creating patches with opioid abuse prevention technology and other innovative products. This chart shows projected revenue for the entire pharmaceutical sector, reflecting analysts' expectations for growth in the transdermal drug delivery system market.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772513916506 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
Nutriband is developing transdermal drug delivery patches. The company is in the development stage, and its future depends on the successful commercialization of its technologies. This overall economic activity schedule impacts the availability of venture capital needed to fund R&D and bring its products to market.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513916550 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Nutriband Inc.
Nutriband develops transdermal drug delivery patches. This metric reflects the financial trajectory of the developer. It demonstrates how successfully the company converts revenue from partnerships or early sales into profits while continuing to invest in research to bring new products to market.
Market segment marginality - Narco farm
Nutriband Inc. develops transdermal drug delivery patches. The company's profitability will depend on the commercialization of its technologies and partnerships with pharmaceutical companies. This metric reflects its operational structure during the R&D phase compared to other companies in this pharmaceutical niche.
Market marginality as a whole
Nutriband develops transdermal drug delivery patches. Their flagship product is a patch with aversion technology to prevent opioid abuse. Their success depends on clinical trials and partnerships with pharmaceutical companies. This overall profitability curve doesn't affect their R&D, but it is important for attracting investment.
Employees in the company, segment and market as a whole
Number of employees in the company Nutriband Inc.
Nutriband develops transdermal drug delivery patches. While in the development stage, the company has a small team. This chart shows the dynamics of the team of scientists and engineers working on the creation and preclinical testing of their innovative products, including a patch for opioid abuse prevention.
Share of the company's employees Nutriband Inc. within the market segment - Narco farm
Nutriband develops transdermal drug delivery patches. This chart shows the share of chemists and pharmacologists in this niche the company attracts. Its small but focused team is working on creating convenient and effective methods for delivering medications through the skin, from painkillers to contraceptives.
Number of employees in the market segment - Narco farm
Nutriband Inc. develops transdermal drug delivery patches, including those with opioid abuse prevention technology. This chart shows overall employment in the pharmaceutical sector. It illustrates how the company is addressing an important medical need by offering an innovative approach to the safe delivery of potent drugs.
Number of employees in the market as a whole
Nutriband Inc. is developing transdermal drug delivery patches, including a patch to prevent opioid abuse. This is an important development in public health. This chart illustrates the pharmaceutical labor market, where innovative companies like Nutriband are creating jobs for chemists, engineers, and clinical specialists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Nutriband Inc. (NTRB)
Nutriband Inc. develops transdermal drug delivery patches, including those with opioid abuse prevention technology. This chart shows how the market values this medical technology. The high market capitalization per employee suggests that investors see potential in unique patents and developments, rather than in current operations.
%20of%20the%20company%20Nutriband%20Inc.%20(NTRB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Nutriband-Inc.-NTRB&v=1772513916807 "Chart of market capitalization per employee (in thousands of dollars) of the company Nutriband Inc. (NTRB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Nutriband develops transdermal drug delivery patches. The company operates at the intersection of pharmaceuticals and technology. Their value is determined by the potential of their developments and patents. This metric reflects how the market values their innovative active ingredient delivery technology. A high value reflects investors' bet that their patches will become a sought-after product.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772513916811 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Nutriband Inc. develops transdermal drug delivery patches. The company is in the development stage. Its valuation is based on the potential of its technology and specific products, such as an opioid abuse prevention patch. The high valuation reflects expectations for future approvals and sales.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513916848 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Nutriband Inc. (NTRB)
Nutriband (NTRB) is a biotech R&D company specializing in the development of transdermal patches. Their flagship product is an abuse-resistant fentanyl patch. This chart shows the net loss (R&D costs) per scientist working on this technology.
%20Chart%20Nutriband%20Inc.%20(NTRB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Nutriband-Inc.-NTRB&v=1772513916866 "Company Profit Per Employee (in thousands of dollars) Chart Nutriband Inc. (NTRB)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Nutriband is developing transdermal drug delivery patches. For a company in the preclinical stage, this metric is irrelevant. The graph shows the industry norm. If their technology is successful, the NTRB will be able to license it, which would generate high profits with minimal staffing, far exceeding the industry benchmark.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772513916895 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Nutriband (NTRB) develops transdermal patches (a technology for delivering medications through the skin), including for opioid abuse prevention. This is R&D in the field of pharmacology. This graph shows that the company is in the development stage. Its profit per employee is negative, as the research team has not yet brought the product to market.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513916911 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Nutriband Inc. (NTRB)
For Nutriband, a company developing transdermal drug delivery patches, this graph reflects the commercialization stage. Revenue per employee growth will depend on the successful launch of its innovative products, which combine pharmaceuticals and patch technology.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Nutriband-Inc.-NTRB&v=1772513916939 "Sales chart per company employee Nutriband Inc. (NTRB)")
Sales per employee in the market segment - Narco farm
Nutriband is a company specializing in transdermal drug delivery patches, including opioid abuse prevention patches. This is R&D. This metric reflects the average revenue per employee in the segment. It helps assess how productive their R&D team is in advancing their technologies compared to other pharmaceutical companies.
Sales per employee for the market as a whole
Nutriband (NTRB) is developing transdermal drug delivery patches. It is an R&D company in the development stage. This indicator is an indicator of the future for NTRB. Zero values currently reflect the R&D stage. An upward trend in the graph would indicate that their patch technology (for example, for ADHD treatment or contraception) has been approved and is commercially available.
Short shares by company, segment and market as a whole
Shares shorted by company Nutriband Inc. (NTRB)
Nutriband is an early-stage company developing transdermal drug delivery patches, including an attempt to create a patch to prevent opioid abuse. This chart reflects investor bets that its technology will fail to prove effective or that the company will fail to secure FDA approval for its flagship product.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Nutriband-Inc.-NTRB&v=1772513916983 "Short Shares Chart for the Company Nutriband Inc. (NTRB)")
Shares shorted by market segment - Narco farm
Nutriband (NTRB) develops transdermal drug delivery technologies, including a fentanyl patch with abuse-resistant properties. This chart shows the overall short position in the specialty pharmaceuticals sector. It reflects market skepticism regarding the effectiveness of their technology or the long and costly path to FDA approval.
Shares shorted by the overall market
Nutriband is a company working on transdermal drug delivery technologies. This is largely a speculative R&D story. When this market fear indicator rises, investors' risk appetite plummets. They sell off unprofitable stocks, like NTRB, whose fate depends on R&D.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Nutriband Inc. (NTRB)
This chart for Nutriband shows speculative interest in new drug delivery systems. The company is developing transdermal patches, including those with opioid abuse prevention technology. Positive news from the FDA or the announcement of a partnership with a major pharma causes the stock to be "overheated" (above 70). Delays in clinical trials or regulatory hurdles lead to "oversold" conditions.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Nutriband-Inc.-NTRB&v=1772513917009 "RSI 14 indicator chart for the company's stock Nutriband Inc. (NTRB)")
RSI 14 Market Segment - Narco farm
Nutriband (NTRB) is the "patch" 2.0. They're *not* Johnson & Johnson, but a developer (R&D) of *transdermal patches* (TDS) for *delivering* drugs (e.g., *cannabinoids*). The "Narco farm" (cannabis/biotech) sector thrives on hype. RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is NTRB's growth a niche product or a result of the *general* hype?
RSI 14 for the overall market
Nutriband (NTRB) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NTRB (Nutriband Inc.)
Nutriband is a company specializing in transdermal patches. It is developing both drug delivery patches (such as CBD) and its flagship product, AVERSA, an opioid abuse treatment patch. This chart shows the speculative average price target from analysts based on R&D.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NTRB-Nutriband-Inc.&v=1772513917064 "A chart showing analyst consensus forecasts for the expected stock price. NTRB (Nutriband Inc.)")
The difference between the consensus estimate and the actual stock price NTRB (Nutriband Inc.)
NTRB - Nutriband is a company developing patches (transdermal systems). Its flagship product is a difficult-to-crack opioid abuse patch. This chart measures the gap between the current price and the consensus target price. It shows the potential analysts see in this technology to combat the opioid crisis.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NTRB-Nutriband-Inc.&v=1772513917065 "A chart showing the difference between the consensus forecast and the actual stock price. NTRB (Nutriband Inc.)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Nutriband (NTRB) is a biopharmaceutical company developing transdermal patches (delivered through the skin), including an opioid abuse-resistant patch. This chart shows general expectations for the pharmaceutical sector. It reflects whether experts believe the patch market will grow as an alternative to pills.
Analysts' consensus forecast for the overall market share price
Nutriband is a company specializing in the development of transdermal patches (for drug delivery through the skin), including for the cannabidiol (CBD) market. This chart shows the overall risk appetite. For Nutriband, which operates at the intersection of biotech and cannabis, overall market optimism is important for funding clinical trials and overcoming regulatory hurdles.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Nutriband Inc.
Nutriband (NTRB) is a platform company. Their specialty is transdermal patches. They use their technology (Aversa) to deliver drugs through the skin, with a focus on abuse (their patches are difficult to grind). This graph represents their R&D bet. It measures their ability (after the COVID patch fiasco) to find a viable market for their delivery technology.
AKIMA Market Segment Index - Narco farm
Nutriband is a company developing transdermal patches for drug delivery, including the AVERSA system, which prevents opioid abuse. This chart shows the average index for the pharmaceutical sector. It helps investors assess how promising Nutriband's technology is compared to the average.
The AKIM Index for the overall market
Nutriband is a company developing transdermal systems (patches), including those with opioid abuse prevention technology (AVERSA). This chart, which reflects the market average, provides a macro backdrop. It helps assess how this niche pharmaceutical company stacks up against overall economic trends.
